DFSVX | VSCVX | DFSVX / VSCVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 32 years | 21 years | - |
Gain YTD | 11.502 | 7.697 | 149% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17B | 1.26B | 1,346% |
Annual Yield % from dividends | 1.44 | 0.83 | 174% |
Returns for 1 year | 25.49 | 9.90 | 258% |
Returns for 3 years | 11.27 | -19.47 | -58% |
Returns for 5 years | 60.36 | 13.30 | 454% |
Returns for 10 years | 56.09 | 22.10 | 254% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DSCIX | 15.44 | 0.23 | +1.51% |
Dana Epiphany Small Cap Eq Instl | |||
FVRMX | 31.53 | 0.39 | +1.25% |
Franklin Mutual Small-Mid Cap Val Adv | |||
FBTAX | 34.43 | 0.36 | +1.06% |
Fidelity Advisor Biotechnology A | |||
PLFPX | 29.35 | 0.13 | +0.44% |
Principal Large Cap S&P 500 Index R5 | |||
VTAIX | 12.01 | 0.04 | +0.33% |
Virtus Tactical Allocation I |